Private Capital Group’s GSK GSK Stock Holding History

Private Capital Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$53K	Buy	961 +39	+4%	+$2.15K	0.04%	458
2022 Q1	$51K	Buy	922 +60	+7%	+$3.26K	0.01%	639
2021 Q4	$48K	Sell	862 -88	-9%	-$4.58K	0.01%	706
2021 Q3	$46K	Sell	950 -206	-18%	-$10.3K	0.01%	718
2021 Q2	$58K	Buy	1,156 +226	+24%	+$10.9K	0.01%	611
2021 Q1	$42K	Sell	930 -1,572	-63%	-$71.4K	0.01%	727
2020 Q4	$117K	Sell	2,502 -491	-16%	-$22.6K	0.02%	452
2020 Q3	$143K	Sell	2,993 -386	-11%	-$19.3K	0.03%	352
2020 Q2	$174K	Sell	3,379 -281	-8%	-$14.4K	0.04%	308
2020 Q1	$176K	Buy	3,660 +705	+24%	+$37.6K	0.05%	268
2019 Q4	$175K	Buy	2,955 +121	+4%	+$6.73K	0.04%	297
2019 Q3	$153K	Buy	2,834 +189	+7%	+$9.72K	0.03%	353
2019 Q2	$135K	Sell	2,645 -53	-2%	-$2.66K	0.03%	303
2019 Q1	$143K	Buy	2,698 +948	+54%	+$47.4K	0.03%	358
2018 Q4	$85K	Sell	1,750 -1,935	-53%	-$95.3K	0.02%	436
2018 Q3	$187K	Buy	3,685 +15	+0.4%	+$762	0.04%	263
2018 Q2	$186K	Buy	3,670 +559	+18%	+$28.2K	0.04%	255
2018 Q1	$154K	Buy	3,111 +1,717	+123%	+$80K	0.03%	293
2017 Q4	$151	Buy	+1,394	New	+$64.4K	0.04%	290

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Private Capital Group's GSK Position: Q2 2022 in Review

Private Capital Group increased its GSK (GSK) stake by 4.2% in Q2 2022, buying an estimated $2.15K and bringing the position to 961 shares worth $53K. The position accounts for 0.04% of the portfolio, ranked #458.

Private Capital Group first reported a position in GSK in Q4 2017 and has held it in 19 quarters since. The position peaked at $187K in Q3 2018. 901 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

Private Capital Group held 961 shares of GSK worth $53K as of Q2 2022.
Private Capital Group bought 39 GSK shares in Q2 2022, an estimated $2.15K.
GSK made up 0.04% of Private Capital Group's portfolio in Q2 2022, its #458 holding.
Private Capital Group first reported a position in GSK in Q4 2017 and has held it in 19 quarters since.
Private Capital Group's GSK position peaked at $187K in Q3 2018.
901 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.